US Oncology’s commitment to research — especially in the community setting — is reflected in the support provided to network practices by the corporate infrastructure. We have over 500 full-time employees dedicated to US Oncology Research, both in the central office and research sites. Our support staff assists practices in ways that help the practice staff focus on patient care rather than administrative red tape.
This centralized support and proven research efficiencies include:
• Scientific and clinical thought leadership • Biostatistics and medical writing services • Centralized regulatory processes and document preparation • Dedicated IRB to approve eight trials per month • Dedicated project management support for each trial • Central investigational pharmacy • One contract, one budget • Tissue banking and analysis — molecular profiling
Publication Support Working with the biostatistics and medical writing services team, physicians have the opportunity to gain invaluable assistance in taking an investigator-initiated trial from concept to publication. In fact, US Oncology Research has produced over 67 manuscripts for investigator-initiated studies that have been published in peer-reviewed journals.
US Oncology Research publication and presentation accomplishments from 1999-2010 include:
World Lung Cancer
With the support provided by US Oncology Research, many practices have also been recognized with the ASCO Clinical Trial Participation Award for demonstrating significant scientific and medical leadership.
Comprehensive Cancer Centers of Nevada Yakima Valley Memorial Hospital / North Star Lodge
Texas Oncology (Baylor Sammons Cancer Center)
Northwest Cancer Specialists Cancer Centers of Carolinas
New York Oncology Hematology Rocky Mountain Cancer Centers
Cedar Rapids Oncology Kansas City Cancer Center Texas Oncology (Presbyterian)
Metro Minnesota (MOHPA) Texas Oncology (Tyler) Virginia Oncology Associates
Our Milestones Since 1999, physicians in the US Oncology Research network have played prominent roles in major scientific and medical symposia, and have presented hundreds of abstracts that helped to change the course of the disease. The network has published more than 67 articles in peer-reviewed journals from investigator-initiated studies, and hundreds more through sponsor-initiated trials.
Every year since 2004, physicians from the US Oncology Research network have been honored with the American Society of Clinical Oncology (ASCO) Clinical Trial Participation Award. To date, 13 practices in the network have received this award.
Here are yearly milestones from our last decade of service:
2001 Five research papers co-authored by four physicians affiliated with US Oncology are published by the American Society of Clinical Oncology (ASCO) in the Journal of Clinical Oncology as classics in lung cancer research. Return to top
2002 US Oncology Research is chosen to participate in a landmark clinical trial to study new approaches to the postoperative use of chemotherapy and the molecularly targeted drug Herceptin® (trastuzumab), also known as “adjuvant” therapy, for women with early stage breast cancer. Return to top
2004 US Oncology researchers play a key role in the promising clinical trials of the investigational agent Abraxane®, presenting their data at the American Society of Clinical Oncology (ASCO) Annual Meeting. Return to top
2005 Researchers affiliated with the network present key findings of several breast cancer clinical research studies at the San Antonio Breast Cancer Symposium (SABCS). Return to top
2006 US Oncology Research joins with the Molecular Profiling Institute to create the Tissue Banking and Analysis Center. Return to top
2007 US Oncology Research achieves 200 accruals for Phase I trials, and network physician Robert S. Miller, M.D. is elected to the Board of Directors of the American Society of Clinical Oncology (ASCO). Return to top
2008 Radiation therapy clinical trials through the Radiation Therapy Oncology Group (RTOG) are initiated to increase patient access to radiation clinical trials. Return to top
2009 US Oncology Clinical Development, an oncology-focused contract research organization (CRO), is launched to complete the continuum of research services offered through US Oncology.
More than 50 physicians affiliated with US Oncology present orals, posters and poster discussions at ASCO.
US Oncology Research participates in record-breaking presentations at the American Society of Clinical Oncology ASCO Annual Meeting and San Antonio Breast Cancer Symposium SABCS.
In only its second year as an Affiliate Member of Radiation Therapy Oncology Group (RTOG), US Oncology Research enrolled the second highest number of patients RTOG clinical trials. Return to top
Contact Us Today Interested in learning more about the US Oncology Research network? Fill in our simple form and we’ll contact you within two business days. Contact Us